Research Nester published a report titled Osteoarthritis Treatment Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers detailed overview of the global osteoarthritis treatment market in terms of market segmentation by drug class, route of administration, disease type, distribution channel, and by region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with a detailed discussion on current and future market trends that are associated with the growth of the market.

The global osteoarthritis treatment market is estimated to garner a notable CAGR over the forecast period, i.e., 2022 –  2031. The market is segmented by distribution channel into hospital, retail, and online pharmacies. Out of which, the hospital sub-segment is expected to hold the largest share in the global osteoarthritis treatment market on account of a large number of patients getting admitted to the hospitals. As hospitals are equipped with ultra-modern machines and talented doctors, a plethora of patients is seeking treatment in the hospitals.


The global osteoarthritis treatment market is expected to grow remarkably on the back of increased incidences of osteoarthritis. Moreover, obese people are highly susceptible to osteoarthritis. The report published by the World Obesity Federation predicts that 1 billion people globally, including 1 in 7 men and 1 in 5 women will be living with obesity by 2030. Osteoarthritis is also caused by joint injuries, such as, bone fracture, cartilage, or ligament tear. The excess weight adds pressure and stress on joint, which is the reason the global osteoarthritis treatment market is projected to grow during the forecast period.

Regionally, the global osteoarthritis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the global osteoarthritis treatment market region is estimated to witness modest growth over the forecast period on the back of the presence of advanced healthcare infrastructure in the region. According to the data released by the Centers for Diseases Control and Prevention, osteoarthritis affects over 32.5 million US adults. Furthermore, obesity is also prevailing in the North America region. Owing to this, the global osteoarthritis treatment market growth is estimated to propel during the forecast period.

The research is global in nature and covers detailed analysis on the market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising market size, Y-O-Y growth & opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

Rising Geriatric Population to Boost the Market Growth

According to the World Population Ageing 2019 report published by United Nations, there were 703 million people aged 65 years or over in the world in 2019.

Osteoarthritis is predicted to be inevitable in the elderly generation. Hence, on the back of the rising geriatric population worldwide, the global osteoarthritis treatment market growth is projected to boost during the forecast period.

However, lack of awareness is expected to operate as a key restraint to the growth of the global osteoarthritis treatment market over the forecast period.

This report also provides the existing competitive scenario of some of the key players of the global osteoarthritis treatment market which includes company profiling of Sanofi-aventis Groupe, GlaxoSmithKline plc., Pfizer Inc., Bayer AG, Zimmer Biomet Holding Inc., Horizon Therapeutics plc, Johnson & Johnson Services, Inc., Novartis AG, Ferring Group, and Merck & Co., Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global osteoarthritis treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.     

Request Report Sample@

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided the right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decisions in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel

Email: [email protected]

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919